The groundbreaking therapy of tirzepatide peptide represents a major development in the handling of the condition. Distinct from existing therapies, tirzepatide affects dual pathways – glucagon-like peptide-1 (GLP-1) https://tirzepatide-peptide901326.aioblogs.com/94738948/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment